These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 21085635)

  • 21. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
    Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
    J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune restoration under HAART in patients chronically infected with HIV-1: diversity of T, B, and NK immune responses.
    Le Guillou-Guillemette H; Renier G; Vielle B; Abgueguen P; Chennebault JM; Lunel F; Payan C
    Viral Immunol; 2006; 19(2):267-76. PubMed ID: 16817769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial.
    Rusconi S; Vitiello P; Adorni F; Colella E; Focà E; Capetti A; Meraviglia P; Abeli C; Bonora S; D'Annunzio M; Di Biagio A; Di Pietro M; Butini L; Orofino G; Colafigli M; d'Ettorre G; Francisci D; Parruti G; Soria A; Buonomini AR; Tommasi C; Mosti S; Bai F; Di Nardo Stuppino S; Morosi M; Montano M; Tau P; Merlini E; Marchetti G
    PLoS One; 2013; 8(11):e80157. PubMed ID: 24244635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART.
    Gómez CE; Perdiguero B; García-Arriaza J; Cepeda V; Sánchez-Sorzano CÓ; Mothe B; Jiménez JL; Muñoz-Fernández MÁ; Gatell JM; López Bernaldo de Quirós JC; Brander C; García F; Esteban M
    PLoS One; 2015; 10(11):e0141456. PubMed ID: 26544853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort.
    Nicoli F; Chachage M; Clowes P; Bauer A; Kowour D; Ensoli B; Cafaro A; Maboko L; Hoelscher M; Gavioli R; Saathoff E; Geldmacher C
    BMC Infect Dis; 2016 Jul; 16():344. PubMed ID: 27450538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up.
    Hejdeman B; Leandersson AC; Fredriksson EL; Sandström E; Wahren B; Bratt G
    HIV Med; 2003 Apr; 4(2):101-10. PubMed ID: 12702130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
    Resino S; Galán I; Bellón JM; Navarro ML; León JA; Muñoz-Fernandez MA
    J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trial.
    Lebouché B; Jenabian MA; Singer J; Graziani GM; Engler K; Trottier B; Thomas R; Brouillette MJ; Routy JP
    Trials; 2014 Oct; 15():390. PubMed ID: 25293882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
    Guadalupe M; Reay E; Sankaran S; Prindiville T; Flamm J; McNeil A; Dandekar S
    J Virol; 2003 Nov; 77(21):11708-17. PubMed ID: 14557656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
    J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes.
    Costa P; Rusconi S; Mavilio D; Fogli M; Murdaca G; Pende D; Mingari MC; Galli M; Moretta L; De Maria A
    AIDS; 2001 May; 15(8):965-74. PubMed ID: 11399978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection.
    Lange CG; Lederman MM; Medvik K; Asaad R; Wild M; Kalayjian R; Valdez H
    AIDS; 2003 Sep; 17(14):2015-23. PubMed ID: 14502004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
    Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
    J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CD8⁺ memory stem T cell (T(SCM)) subset is associated with improved prognosis in chronic HIV-1 infection.
    Ribeiro SP; Milush JM; Cunha-Neto E; Kallas EG; Kalil J; Somsouk M; Hunt PW; Deeks SG; Nixon DF; SenGupta D
    J Virol; 2014 Dec; 88(23):13836-44. PubMed ID: 25253339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis.
    Tasca S; Tambussi G; Nozza S; Capiluppi B; Zocchi MR; Soldini L; Veglia F; Poli G; Lazzarin A; Fortis C
    AIDS; 2003 Nov; 17(16):2291-8. PubMed ID: 14571180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease.
    Valdez H; Connick E; Smith KY; Lederman MM; Bosch RJ; Kim RS; St Clair M; Kuritzkes DR; Kessler H; Fox L; Blanchard-Vargas M; Landay A;
    AIDS; 2002 Sep; 16(14):1859-66. PubMed ID: 12351945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
    Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
    Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).
    Boström AC; Hejdeman B; Matsuda R; Fredriksson M; Fredriksson EL; Bratt G; Sandström E; Wahren B
    Vaccine; 2004 Apr; 22(13-14):1683-91. PubMed ID: 15068851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine.
    Cafaro A; Tripiciano A; Sgadari C; Bellino S; Picconi O; Longo O; Francavilla V; Buttò S; Titti F; Monini P; Ensoli F; Ensoli B
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S13-29. PubMed ID: 26096836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.